Skip to main content
Unchecking box will stop auto data updates
Cboe BZX Real-Time Last Sale USD
Today's Change
Volume
Price Quote as of

Today's Trading

Day Low 93.40
Day High 94.64
Open:93.48
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Trailing Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.

More stories below advertisement

Description
AbbVie is a global, research-based biopharmaceutical company. AbbVie combines the focus and passion of a leading-edge biotech with the expertise and structure of a long-established pharmaceutical leader. The company's mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world's most complex and serious diseases. AbbVie aims to help patients' live healthier lives and collaborate on sustainable healthcare solutions.

Fundamentals

Market Capitalization, $M
Shares Outstanding, M
36-Month Beta
Earnings Per Share (TTM)
Revenue Growth YoY
Profit Margin
5-Year Avg. Revenue Growth
5-Year Avg. Profit Growth
1-Year Total Return
3-Year Total Return
5-Year Total Return
Price/Earnings (TTM)
Price/Earnings (Forward)
Trailing Annual Dividend & Yield
Forward Annual Dividend & Yield
Most Recent Dividend
Ex-Div Date
Most Recent Split
Return on Common Equity
Return-on-Assets (Before Tax)
Debt-to-Equity Ratio
Price/Book

Earnings

Corporate earnings are provided from Zacks Investment Research, including Income Statements, Balance Sheets, Cash Flow Statements, and Statement of Retained Earnings.

Analyst Research

Analyst Ratings and Earnings Estimates are provided by Zacks Investment Research – including Buy/Hold Recommendations, Earnings Surprises, Estimates and Recommendations History.

Stock Reports +

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

StockCalc Reports

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

Latest Press Releases

CLASS ACTION ALERT: Brower Piven Notifies Investors of Class Action Lawsuit And Encourages Those Who Have Significant Losses From Investment In AbbVie Inc. (NYSE: ABBV) To Contact Brower Piven Before The Lead Plaintiff Deadline
GlobeNewswire - Mon Sep 24, 2:58PM CDT
GlobeNewswire - CMTX
Mon Sep 24, 2:58PM CDT
The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Central District of California on behalf of purchasers of AbbVie Inc. (NYSE: ABBV) ("AbbVie" or the "Company") securities during the period between October 25, 2013 and September 18, 2018, inclusive (the "Class Period"). Investors who wish to become proactively involved in the litigation have until November 20, 2018 to seek appointment as lead plaintiff.
ABBVIE INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $500,000 Investing In AbbVie Inc. To Contact The Firm
PR Newswire - Mon Sep 24, 1:58PM CDT
PR Newswire - CMTX
Mon Sep 24, 1:58PM CDT
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against AbbVie Inc. ("AbbVie" or the "Company") (NYSE:ABBV).
IMPORTANT INVESTOR NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against AbbVie Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
BusinessWire - Mon Sep 24, 10:54AM CDT
BusinessWire - CMTX
Mon Sep 24, 10:54AM CDT
The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against AbbVie Inc. ("AbbVie" or "the Company") (NYSE: ABBV) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Price History Describes more index sector components

Price Performance

Period Period Low Period High Performance
1-Month 90.40 +3.74% increase
on 09/19/18
Period Open:97.40
Price movement based on the high, low and last over the given period.
98.70 -4.98% decrease
on 08/28/18
-3.62 (-3.72%) decrease
since 08/24/18
3-Month 86.76 +8.09% increase
on 07/20/18
Period Open:93.05
Price movement based on the high, low and last over the given period.
100.23 -6.44% decrease
on 08/20/18
+0.73 (+0.78%) increase
since 06/25/18
52-Week 83.19 +12.73% increase
on 09/27/17
Period Open:86.57
Price movement based on the high, low and last over the given period.
125.86 -25.49% decrease
on 01/26/18
+7.21 (+8.33%) increase
since 09/25/17

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2018.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

More stories below advertisement